| Primary information |
|---|
| sequence ID | Seq_1765 |
| Peptide sequence | EEYTKKLNTQ |
| CancerPDF_ID | CancerPDF_ID126, CancerPDF_ID3432, CancerPDF_ID3554, CancerPDF_ID9552, |
| PMID | 17269714,27026199,27026199,21533267 |
| Protein Name | Apolipoprotein A-I,Apolipoprotein A-I,Apolipoprotein A-I,Apolipoprotein A-I |
| UniprotKB Entry Name | APOA1_HUMAN,APOA1_HUMAN,APOA1_HUMAN,APOA1_HUMAN |
| Fluid | Plasma,Urine,Urine,Serum |
| M/Z | NA,NA,NA,627.34 |
| Charge | 1,NA,NA,2 |
| Mass (in Da) | 1253.64,NA,NA,NA |
| fdr | NA,1252.64,1252.63,NA |
| Profiling Technique | MALDI-TOF,"CE-MS, Micro-TOF-MS","CE-MS, Micro-TOF-MS",LC-MS |
| Peptide Identification technique | LC-MS/MS,MS-MS,MS-MS,LC/MS/MS |
| Quantification Technique | NA,NA,NA,Multiple Reaction Monitoring |
| Labelled/Label Free | Label Free,Label Free,Label Free,Label Free |
| FDR | NA,NA,NA,1.49 |
| CancerPDF_ID | CancerPDF_ID126, CancerPDF_ID3432, CancerPDF_ID3554, CancerPDF_ID9552, |
| p-Value | NA,less than 0.05,3.30E-04,NA |
| Software | MASCOT (v 2.1.0),Proteome Discoverer 1.2,Proteome Discoverer 1.2,MASCOT |
| Length | 10,10,10,10 |
| Cancer Type | Normal,Bladder cancer,Bladder cancer,Lung adenocarcinoma |
| Database | MSDB Human Database,Uniprot Human non-redundant Database,Uniprot Human non-redundant Database,Swissprot Database (57.4) |
| Modification | NA,NA,NA,NA |
| Number of Patients | NA,451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls);, 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls),62 lung adenocarcinoma and 30 healthy control |
| Regulation | NA,Differentially expressed between primary UBC and normal individual,Differentially expressed between recurrence of UBC vs recurrence control,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" |
| Validation | NA,Independent Validation,Independent Validation,MRM-based validation of 19 candidates |
| Sensitivity | NA,For testing dataset 91%,For testing dataset 88%,NA |
| Specificity | NA,For testing dataset 68%,For testing dataset 51%,NA |
| Accuracy | NA,For testing dataset 76%,NA,NA |
| Peptide Atlas | NA |
| IEDB | 120086
|